|
DDX27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.991630E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.363500E-03 |
| Normal-vs-Stage2 |
3.924400E-03 |
| Normal-vs-Stage3 |
1.781200E-04 |
| Normal-vs-Stage4 |
3.965000E-03 |
| Stage1-vs-Stage2 |
2.444000E-01 |
| Stage1-vs-Stage3 |
1.724430E-01 |
| Stage1-vs-Stage4 |
4.311000E-01 |
| Stage2-vs-Stage3 |
8.533600E-01 |
| Stage2-vs-Stage4 |
7.310000E-01 |
| Stage3-vs-Stage4 |
8.141200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.476910E-03 |
| Normal-vs-AfricanAmerican |
2.400000E-01 |
| Normal-vs-Asian |
1.132190E-01 |
| Caucasian-vs-AfricanAmerican |
4.919200E-01 |
| Caucasian-vs-Asian |
5.866200E-01 |
| AfricanAmerican-vs-Asian |
8.035600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.632100E-04 |
| Normal-vs-Female |
6.575400E-04 |
| Male-vs-Female |
4.260200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.848230E-02 |
| Normal-vs-Age(41-60Yrs) |
8.197800E-04 |
| Normal-vs-Age(61-80Yrs) |
4.12409999994701E-06 |
| Normal-vs-Age(81-100Yrs) |
1.979980E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.786000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.603900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.962500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.287600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.370800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.140400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.912500E-02 |
| Classical-VS-Follicular |
1.14829999997568E-06 |
| Classical-VS-Other |
6.743400E-01 |
| Classical-VS-Normal |
1.254030E-01 |
| Tall-VS-Follicular |
1.663420E-01 |
| Tall-VS-Other |
8.652400E-01 |
| Tall-VS-Normal |
4.382100E-03 |
| Follicular-VS-Other |
3.477400E-01 |
| Follicular-VS-Normal |
1.89240000003643E-07 |
| Other-VS-Normal |
4.454600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51078999999221E-05 |
| Normal-vs-N1 |
1.645720E-02 |
| N0-vs-N1 |
4.979000E-01 |
|
|
